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Purpose: The objective of this study was to formulate and evaluate a matrix microsphere system for 
simultaneous delivery of two anti-asthmatic drugs Salbutamol sulphate and Theophylline which are often 
indicated for the management of asthma, their frequent dosing may reduce compliance, thus making a 
prolonged release formulation necessary. Ethylcellulose was used as a retardant polymer and its 
compatibility with the drugs and the drug-drug compatibility were established through IR, XRD and DSC 
studies.  
Method: Microspheres were prepared by emulsion solvent evaporation using acetone/light liquid 
paraffin system. Tween 80 was used as the dispersing agent and cyclohexane was added to harden the 
microspheres. The prepared microspheres were characterized for their micromeritic properties and drug 
loading, as well as by infrared spectroscopy (IR), differential scanning calorimetry (DSC), x-ray powder 
diffractometry (XRD) and scanning electron microscopy (SEM). The in vitro release studies were 
performed in pH 7.4, phosphate buffer. 
Result: The prepared microspheres were white, free flowing and spherical in shape. The drug-loaded 
microspheres showed 67-91% of entrapment and release was extended upto 6 to 8 h. The infrared 
spectra, differential scanning calorimetry thermographs and XRD spectra all showed the stable 
character of both the drugs in the drug-loaded microspheres and revealed the absence of drug-polymer 
interactions. Scanning electron microscopy study revealed that the microspheres were spherical and 
porous in nature.  
Conclusion: The matrix microspheres have a potential for the prolongation and simultaneous delivery 
of the anti asthmatic drugs (salbutamol and theophylline). 
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INTRODUCTION 
 
Patients suffering from chronic diseases 
like asthma, diabetes and epilepsy may 
have to take drugs everyday for the rest of 
their life
3
. WHO estimates the number of 
asthmatic patients to be around 100 to 150 
millions around the world and India 
contribute 10 % of the total and its 
incidence is escalating every decade at an 
alarming rate. In management of chronic 
diseases like asthma, compliance to the 
dosage regimen is the key to a successful 
therapy. Patient may be treated with more 
than one drug and compliance is found to 
be low in such cases.  
 
The short half life (4 to 6 hours) with 
extensive first pass metabolism of 
salbutamol and the propensity for 
interaction and narrow therapeutic index 
(10 to 20 µg/ml) of theophylline are well 
known. Although salbutamol and theophylline 
are often indicated for the management of 
asthma, their frequent dosing may reduce 
compliance, thus making a prolonged release 
formulation necessary. Theophylline 
produced an additive effect when used in 
combination with salbutamol sulphate
4
. 
Different controlled release dosage forms 
for simultaneous delivery of salbutamol and 
theophylline have been proposed by 










. Both salbutamol and 
theophylline are readily and well absorbed 
along the gastrointestinal tract. Even when 
salbutamol is given as an inhalation, it has 
been suggested that majority of the dose is 
swallowed and absorbed from the gut
8
. 
Microencapsulation is used to modify and 
retard drug release. Microspheres, due to its 
small particle size, are widely distributed 
throughout the gastrointestinal tract which 
improves drug absorption and reduces side-
effects due to localized build-up of irritating 
drugs against the gastrointestinal mucosa
9
. 
The objective of the present study includes: 
(a) formulation of a sustained release matrix 
microsphere system containing salbutamol 
sulphate and theophylline using ethylcellulose 
as the retardant polymer which will release the 
drug at the gastrointestinal tract for a prolong 
duration to promote patient compliance; (b) to 
study the effects of drug to polymer ratio on 
in-vitro drug release and (c) to fit the drug 
release data to various drug release models. 
 
MATERIALS AND METHODS 
Materials 
The test drugs, salbutamol sulphate IP and 
anhydrous theophylline IP (Ducbill drugs, 
Kolkatta), the polymeric matrix former 
ethylcellulose (22 cps grade determined at 
80:20 toluene: ethanol, Wilson Brothers, 
Mumbai), and the dispersing agent Tween 80 
(Rankem, New Delhi) were obtained and all 
other chemicals and reagents used were of 
analytical grade. 
Determination of Saturation solubility 
The saturation solubility of both Anhydrous 
theophylline and salbutamol sulphate were 
separately determined at distilled water and 
phosphate buffer pH 7.4 to observe the 
suitability of the solution as a dissolution 
medium (Table 2). Excess amount of the 
drugs were taken and dissolved in a 1 ml of 
phosphate buffer (pH 7.4) and distilled water 
and extracted for 24 hours. After suitable 
dilutions, the concentrations were determined 
spectrophotometrically at 276 nm for 




Preparation of microspheres 
The microspheres were prepared by emulsion 
solvent evaporation technique using the 
formulation as shown in Table 1.  In this 
method 1219.2 mg of ethylcellulose was 
dissolved in 15 ml of acetone and a given 
amount of the drugs were dispersed in it to 
make different drug to polymer ratio of 1:1, 1:2 
and 1:3 and stirred for about 10 minutes. Then 
the polymer drug dispersion was poured into 
50 ml of liquid paraffin (light) containing 
varying concentrations of Tween 80. The 
whole system was then stirred for about 4 
hours at 900 RPM. After stirring process is 
over the liquid paraffin (light) was decanted off 
and the microspheres formed were collected 
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by filtration in a Whatman filter paper and 
washed with Cyclohexane to completely 
remove the remaining oil and dried at 50 ºC in 
Vacuum drier (NSW, India) for 6 hours and 
collected for further studies.  
Particle size determination 
The particle size of the microspheres was 
determined by microscopic method
11
. For 
each batch of the microspheres, 100 particles 
were counted and done in triplicate. 
Drug entrapment efficiency 
The amounts of salbutamol sulphate and 
theophylline present in the microsphere were 
determined by extraction in distilled water
12
. 
50 mg of the crushed and powdered 
microsphere was taken and extracted in 50 ml 
of distilled water and stirred for 15 minutes at 
1500 rpm. The solution was filtered and 
diluted with 0.05 M 
NaOH
 and absorbance 
measured spectrophotometrically (U-2001, 
Hitachi) at 244.6 nm and 276.5 nm and 




In vitro drug release study 
The in-vitro release study of the microsphere 
was carried out using USP rotating basket 
method at 50 rpm at 37 ºC. Dissolution study 
was performed in Phosphate buffer pH 7.4 
taking 900 ml for each study. 100 mg of the 
microsphere was placed in the dissolution 
medium and test samples were taken from the 
medium at predetermined time intervals over 
a period of 12 hours and the samples were 
analyzed for salbutamol sulphate and 
theophylline content UV spectrophotometer.  
 Infrared Spectroscopy 
IR spectra of the pure drugs and 
microspheres were recorded using Perkin-
Elmer model 883 IR-spectrophotometer 
between the ranges of 500 to 4000 cm
-1
 by 
making a pellet of the samples with KBr. The 
resultant spectra were then compared with 
standard reference (IP 1996) and observe for 
any type of deviation from the standard.  
Differential Scanning Calorimeter Analysis 
(DSC) 
DSC thermogram of the pure drugs and the 
microspheres were recorded with a differential 
scanning calorimeter (Universal V2.5H TA 
Instrument) from 20 to 550 ºC at a heating 
rate of 20 ºC/minute.  
X-Ray Diffraction Spectroscopy (XRD) 
 X-ray diffraction spectrum of the pure drug 
and microspheres were recorded with Phillips 
PW 1830 X-ray generator fixed with PW 1710 
diffractometer (Phillips Industrial & Electro-
acoustic Systems Division, Almelo, The 
Netherlands). The XRD was performed at the 
angle between 5-60 ° 2θ. 
Scanning Electron Microscopy (SEM)  
Scanning electron microscopy (Hitachi S-
3600N, Japan) was done to characterize 
surface topography of the microspheres.  
Photomicrograph of the microspheres before 
and after the release of drugs was taken. The 
quality of the microspheres (with respect to 
surface properties) and the nature and size of 
pores developed on the surface can be 
studied. The changes that occur during in-vitro 
dissolution studies may have implications to 
the performance of the microspheres. 
Release Kinetics 
Data obtained from in vitro release studies 
were fitted to various kinetic equations to find 
out the mechanism of drug release from the 
ethylcellulose microsphere. The kinetic 
models used were: 
 
Qt = ko t      (zero-order equation)         ...3 
ln Qt = ln Q0  - k1. t  (first-order equation) …4 
  ….1
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Table 2: Correlation coefficient (r
2
), Constant (K) and Diffusion exponent (n) after fitting of dissolution  
data into various release kinetic models Theophylline 
Zero-Order First-Order Higuchi 
Model 
Korsenmeyer-

















































































































































Figure 1: IR spectra salbutamol sulphate (pure drug), theophylline (pure drug) and microsphere containing the 
two drugs (1:3 drug:polymer).  
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Qt = K .S. √t = kH . √t   ……………5    
(Higuchi eqn based on Fickian diffusion) 
Where, Q is the amount of drug release in 
time t, Q0  is the initial amount of drug in the 
microsphere, S is the surface area of the 
microcapsule and ko  , k1 , and kH are rate 
constant of zero order, first order and Higuchi 
rate equations respectively. In addition to 
these basic release models, there are several 
other models as well. One of them is Peppas 
and Korsenmeyer equation
13,14
 (power law). 
 
Mt / M∞= k · t




Where Mt is the amount of drug release at 
time t and M∞ is the amount release at time t = 
∞, thus Mt / M∞ is the fraction of drug released 
at time t, k is the kinetic constant, and n is the 
diffusion exponent which can be used to 
characterize both mechanism for both solvent 
penetration and drug release. Determining the 
correlation coefficient assessed fitness of the 
data into various kinetic models. The rate 
constants, for respective models were also 
calculated from slope. 
 
RESULTS 
The physicochemical compatibility of the 
drugs and the polymer was established 
through infrared spectroscopy (Figure 1), 
differential scanning colorimetry and x-ray 
diffraction spectroscopy. Results from IR, 
DSC and XRD studies do not show any 
interaction or degradation.  
Scanning Electron Microscopy (SEM): 
Scanning electron microscopy of drugs-loaded 
ethylcellulose microspheres (Figure 2) reveals 
that the microspheres posses a rough and 
rugged surface. The micrograph taken after 
12 hours release studies also reveals porosity 
developed at the surface. The micrographs 
show that porosity developed but structure is 
retained as 12 hours drug release study was 
carried out. 
Entrapment Efficiency: The entrapment 
efficiency determined at phosphate buffer of 
pH 7.4 shows the entrapment efficiency of 
both drugs increase as the polymer 
concentration is increased (Table 1). The 
entrapment efficiency for salbutamol sulphate 
was in the range of 78 (for 1:1 drug:polymer) 
to 83 (for 1:3 drug:polymer)  and for 
theophylline it was in the range of 82 (for 1:1 
Drug:Polymer) to 86 (for 1:3 Drug:Polymer).  
Mean Particle Size: The particle size of the 
microspheres (Table 1) was in the range of 
690 µm to 730 µm.  
Drug Release: The effect of variation in drug 
to polymer ratio on drug release was studied 
on salbutamol sulphate and theophylline 
combination microspheres in a dissolution 
medium of phosphate buffer of pH 7.4. 
Different drug to polymer ratio taken were 1:1, 
1:2 and 1:3 and increase in polymer 
concentration resulted in a decrease of drugs 
release rate. The release of salbutamol 
sulphate was found to be higher as compared 
to theophylline release. Sustained release up 
to 12 hours was achieved when drug: polymer 
was taken up to 1:3. 
The release data obtained were fitted 
into various release kinetic models and 
release kinetics table (Table 2) was prepared. 
 
DISCUSSION 
A matrix microsphere system for sustain 
release of two drugs has been formulated. For 
this type of system it is important that the 
presence of one drug species do not alter the 
physicochemical properties of the other
13
.  
Scanning electron microscopy of drugs-loaded 
ethylcellulose microspheres reveals that the 
microspheres posses a rough and rugged 
surface. It was also observed that after 
dissolution was performed, bigger and more 
pores are developed. The surface porosity is 
crucial for drug release in microspheres 
prepared with ethylcellulose. Since the 
polymer is not biodegradable, the release of 
the drugs from microspheres takes place by 
dissolution and diffusion through the pores. 
Ethylcellulose allows water to permeate 
through its surface without itself dissolving in 
it. The micrographs show that porosity 
developed but structure is retained as 12 
hours drug release study was carried out. 
The entrapment efficiency of both drugs was 
found to increase as the polymer 
concentration is increased, as there were 
more polymeric binding sites for the drugs. 
And as the amount of drug taken is decreased 
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while taking constant amount of the polymer, 
the particle size is decreasing. This may be 
due to the decrease in viscosity of the drug-
polymer dispersion since constant amount of 
polymer was dissolved in acetone and the 




The effect of variation in drug to polymer ratio 
on drug release was due to the increase in 
wall thickness that results in longer diffusion 
path
16
. The release of salbutamol sulphate 
was found to be higher as compared to 
theophylline release, this may be due to the 
higher solubility of salbutamol sulphate than 
theophylline in the dissolution medium.  
 
 
Figure 2: Scanning electron micrographs of salbutamol sulphate-theophylline combination   
microsphere (1:3 drug:polymer) (a) before drug release; (b) after 12 hours of drug release; (c) 
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Figure 3: Higuchi plots for drug release from microsphere (1:2, drug:polymer, 1% Tween 80) 
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Dissolution studies show a sustained release 
upto 12 hours when drug:polymer was taken 
up to 1:3 this may be due to an increase in the 
tortuosity of the diffusion pathlength as the 
amount of the polymer is increased. From the 
release data obtained and the release kinetics 
table (Table 2) it can be observed that the 
best-fit release kinetics was achieved with 
Higuchi plot followed by zero order and First 
order. The release of both the drugs was 
influenced by the drug to polymer ratio and 
was found to be diffusion controlled. So, the 
release of salbutamol sulphate and 
theophylline from the ethylcellulose 
microspheres was found to exhibit diffusional 
characteristics and closely follows Higuchi 
Model and also highly correlated with first-
order release model (Figure 3). 
 
CONCLUSION 
Salbutamol sulphate-theophylline combination 
microspheres was prepared successfully 
using the emulsion solvent evaporation 
method. Taking of different polymer:drug ratio 
is found to influence the size, entrapment 
efficiency and release characteristics of the 
microspheres . The assessment of the release 
kinetics revealed that drug release from the 
microspheres followed Higuchi Model. The 
mechanism of drug release from 
microspheres was diffusion-controlled. Since 
the polymer and the drugs were found to be 
compatible and the release mechanism is 
characterized, there is a great scope for the 
formulation of these antiasthmatic drugs as a 
microsphere system. Since microspheres are 
better distributed and facilitate the absorption 
of drugs from the intestines, this type of 
formulation would help in controlling asthmatic 
attacks to millions of patience suffering from it. 
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